Financials

News Discussions Technicals Forecast Seasonals

EBIT of Anebulo Pharmaceuticals, Inc.

Annual data

2021

2022

2023

2024

TTM

‪‪−12.00 M‬‬

‪‪−9.00 M‬‬

‪‪−6.00 M‬‬

‪‪−3.00 M‬‬

‪0.00‬

Period

Value

Change

Change %

TTM

‪‪−8.00 M‬‬

+‪‪303.87 K‬‬

+‪3.66‬%

2024

‪‪−8.31 M‬‬

+‪‪3.47 M‬‬

+‪29.49‬%

2023

‪‪−11.78 M‬‬

‪‪−4.95 M‬‬

‪−72.50‬%

2022

‪‪−6.83 M‬‬

‪‪−3.22 M‬‬

‪−89.03‬%

2021

‪‪−3.61 M‬‬

‪‪−3.44 M‬‬

‪‪−1.98 K‬‬%

Quarterly data

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

‪‪−3.20 M‬‬

‪‪−2.40 M‬‬

‪‪−1.60 M‬‬

‪‪−800.00 K‬‬

‪0.00‬

Period

Value

Change

Change %

Q2 '25

‪‪−2.59 M‬‬

‪‪−176.03 K‬‬

‪−7.30‬%

Q1 '25

‪‪−2.41 M‬‬

‪‪−1.07 M‬‬

‪−79.96‬%

Q4 '24

‪‪−1.34 M‬‬

+‪‪323.88 K‬‬

+‪19.46‬%

Q3 '24

‪‪−1.66 M‬‬

+‪‪1.10 M‬‬

+‪39.71‬%

Q2 '24

‪‪−2.76 M‬‬

‪‪−216.78 K‬‬

‪−8.52‬%

Q1 '24

‪‪−2.54 M‬‬

‪‪−49.29 K‬‬

‪−1.98‬%

Q4 '23

‪‪−2.49 M‬‬

+‪‪369.65 K‬‬

+‪12.91‬%

Q3 '23

‪‪−2.86 M‬‬

+‪‪949.08 K‬‬

+‪24.89‬%

Q2 '23

Q1 '23

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21